146 related articles for article (PubMed ID: 16187833)
1. Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain.
Conti LH; Costill JE; Flynn S; Tayler JE
Behav Neurosci; 2005 Aug; 119(4):1052-60. PubMed ID: 16187833
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.
Conti LH; Murry JD; Ruiz MA; Printz MP
Psychopharmacology (Berl); 2002 May; 161(3):296-303. PubMed ID: 12021833
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats.
Conti LH
Eur J Pharmacol; 2005 Jan; 507(1-3):125-34. PubMed ID: 15659302
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.
Conti LH; Sutherland JE; Muhlhauser CM
Behav Brain Res; 2009 Jun; 200(1):165-72. PubMed ID: 19373982
[TBL] [Abstract][Full Text] [Related]
5. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
Conti LH
Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
[TBL] [Abstract][Full Text] [Related]
6. Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels.
Vollenweider FX; Barro M; Csomor PA; Feldon J
Biol Psychiatry; 2006 Sep; 60(6):597-603. PubMed ID: 16997001
[TBL] [Abstract][Full Text] [Related]
7. Endogenous kynurenic acid disrupts prepulse inhibition.
Erhardt S; Schwieler L; Emanuelsson C; Geyer M
Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
[TBL] [Abstract][Full Text] [Related]
8. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
Schwabe K; Brosda J; Wegener N; Koch M
Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
[TBL] [Abstract][Full Text] [Related]
9. Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor.
Conti LH; Berridge CW; Tayler JE
Pharmacol Biochem Behav; 2006 Sep; 85(1):261-72. PubMed ID: 16996121
[TBL] [Abstract][Full Text] [Related]
10. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
11. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
[TBL] [Abstract][Full Text] [Related]
12. The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
Feifel D; Melendez G; Priebe K; Shilling PD
Behav Brain Res; 2007 Aug; 181(2):278-86. PubMed ID: 17559953
[TBL] [Abstract][Full Text] [Related]
13. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
14. Prepulse inhibition of acoustic startle in spontaneously hypertensive rats.
van den Buuse M
Behav Brain Res; 2004 Oct; 154(2):331-7. PubMed ID: 15313020
[TBL] [Abstract][Full Text] [Related]
15. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A
J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695
[TBL] [Abstract][Full Text] [Related]
16. Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: comparison with risperidone.
Andreasen JT; Andersen KK; Nielsen EØ; Mathiasen L; Mirza NR
Behav Brain Res; 2006 Feb; 167(1):118-27. PubMed ID: 16225935
[TBL] [Abstract][Full Text] [Related]
17. Seroquel restores sensorimotor gating in phencyclidine-treated rats.
Swerdlow NR; Bakshi V; Geyer MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1290-9. PubMed ID: 8968353
[TBL] [Abstract][Full Text] [Related]
18. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
Levin ED; Petro A; Caldwell DP
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition.
van den Buuse M; Gogos A
J Pharmacol Exp Ther; 2007 Mar; 320(3):1224-36. PubMed ID: 17194799
[TBL] [Abstract][Full Text] [Related]
20. Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia.
Kesby JP; Burne TH; McGrath JJ; Eyles DW
Biol Psychiatry; 2006 Sep; 60(6):591-6. PubMed ID: 16697353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
